You are here: news
Best Secured Loans:
There's a new Investor Edition of CMC Markets' spread betting platform... and it's exclusive to DigitalLook.com users...
Date: Tuesday 26 Feb 2008
LONDON (ShareCast) - BHK, the maker of artificial organs and digital technology, said it will be the first Korean company to be admitted to AIM when it will list its global depository receipts in March.
The group is already listed on the Korea Exchange and has a market capitalisation of about $80m.
“BHK possesses a different business model to traditional biotech companies by combining its two medical arms with the benefits of a cash generative digital division, which provides both revenue and complementary technologies,” said chairman and chief executive Jong Weon Choi.
“Our admission to AIM will raise BHK's international profile in advance of the company's next stage of development into China and ultimately Europe, whilst also providing access to a wider investor base,” he added.
Deloitte Corporate Finance is acting as nominated adviser and Lewis Charles Securities is acting as broker to the company.